Ni Gusti Ayu Nanditha1,2, Grace Zheng2, Hiwot M Tafessu1, Taylor McLinden1, Andreea Bratu1, Jacek Kopec3,4, Robert S Hogg1,5, Julio S G Montaner1,2, Viviane D Lima6,7. 1. British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada. 2. Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. 3. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. 4. Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada. 5. Arthritis Research Canada, Richmond, BC, Canada. 6. British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada. vlima@bccfe.ca. 7. Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. vlima@bccfe.ca.
Abstract
OBJECTIVES: Longer survival has increased the likelihood of antiretroviral-treated people living with HIV (PLWH) developing age-associated comorbidities. We compared the burden of multimorbidity and all-cause mortality across HIV status in British Columbia (BC), and assessed the longitudinal effect of multimorbidity on all-cause mortality among PLWH. METHODS: Antiretroviral-treated PLWH aged ≥19 years and 1:4 age-sex-matched HIV-negative individuals from a population-based cohort were followed for ≥1 year during 2001-2012. Diagnoses of seven age-associated comorbidities were identified from provincial administrative databases and grouped into 0, 1, 2, and ≥3 comorbidities. Multimorbidity prevalence and age-standardized mortality rates (ASMRs) in both populations were stratified by BC's health regions. Marginal structural models were used to estimate the effect of multimorbidity on mortality among PLWH, adjusted for time-varying confounders affected by prior multimorbidity. RESULTS: Among 8031 PLWH and 32,124 HIV-negative individuals, 25% versus 11% developed multimorbidity, and 23.53 deaths/1000 person-years (95% confidence interval [95% CI]: 22.02-25.13) versus 3.04 (2.81-3.29) were observed, respectively. PLWH in Northern region had the highest ASMR, but those in South Vancouver Island experienced the greatest difference in mortality compared with HIV-negative individuals. Among PLWH, compared with those with zero comorbidities, adjusted hazard ratios for those with 1, 2, and ≥3 comorbidities were 3.36 (95% CI: 2.86-3.95), 6.92 (5.75-8.33), and 12.87 (10.45-15.85), respectively. CONCLUSION: PLWH across BC's health regions experience excess multimorbidity and associated mortality. We highlight health disparities which are key when planning the distribution of healthcare resources across BC, and provide evidence for improved HIV care models integrating prevention and management of chronic diseases.
OBJECTIVES: Longer survival has increased the likelihood of antiretroviral-treated people living with HIV (PLWH) developing age-associated comorbidities. We compared the burden of multimorbidity and all-cause mortality across HIV status in British Columbia (BC), and assessed the longitudinal effect of multimorbidity on all-cause mortality among PLWH. METHODS: Antiretroviral-treated PLWH aged ≥19 years and 1:4 age-sex-matched HIV-negative individuals from a population-based cohort were followed for ≥1 year during 2001-2012. Diagnoses of seven age-associated comorbidities were identified from provincial administrative databases and grouped into 0, 1, 2, and ≥3 comorbidities. Multimorbidity prevalence and age-standardized mortality rates (ASMRs) in both populations were stratified by BC's health regions. Marginal structural models were used to estimate the effect of multimorbidity on mortality among PLWH, adjusted for time-varying confounders affected by prior multimorbidity. RESULTS: Among 8031 PLWH and 32,124 HIV-negative individuals, 25% versus 11% developed multimorbidity, and 23.53 deaths/1000 person-years (95% confidence interval [95% CI]: 22.02-25.13) versus 3.04 (2.81-3.29) were observed, respectively. PLWH in Northern region had the highest ASMR, but those in South Vancouver Island experienced the greatest difference in mortality compared with HIV-negative individuals. Among PLWH, compared with those with zero comorbidities, adjusted hazard ratios for those with 1, 2, and ≥3 comorbidities were 3.36 (95% CI: 2.86-3.95), 6.92 (5.75-8.33), and 12.87 (10.45-15.85), respectively. CONCLUSION: PLWH across BC's health regions experience excess multimorbidity and associated mortality. We highlight health disparities which are key when planning the distribution of healthcare resources across BC, and provide evidence for improved HIV care models integrating prevention and management of chronic diseases.
Authors: Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice Journal: J Gen Intern Med Date: 2005-12 Impact factor: 5.128
Authors: Zaake de Coninck; Laith Hussain-Alkhateeb; Göran Bratt; Anna Mia Ekström; Magnus Gisslén; Max Petzold; Veronica Svedhem Journal: AIDS Patient Care STDS Date: 2018-08 Impact factor: 5.078
Authors: Ni Gusti Ayu Nanditha; Martin St-Jean; Hiwot Tafessu; Silvia A Guillemi; Mark W Hull; Michelle Lu; Bonnie Henry; Rolando Barrios; Julio S G Montaner; Viviane D Lima Journal: PLoS One Date: 2019-03-21 Impact factor: 3.240
Authors: Viviane Dias Lima; Oghenowede Eyawo; Huiting Ma; Lillian Lourenço; William Chau; Robert S Hogg; Julio S G Montaner Journal: J Int AIDS Soc Date: 2015-10-07 Impact factor: 5.396
Authors: Oghenowede Eyawo; Mark W Hull; Kate Salters; Hasina Samji; Angela Cescon; Paul Sereda; Viviane D Lima; Bohdan Nosyk; David G T Whitehurst; Scott A Lear; Julio S G Montaner; Robert S Hogg Journal: BMJ Open Date: 2018-01-13 Impact factor: 2.692